Although African horse sickness (AHS) can cause up to 95% mortality in horses, naïve animals can be protected by vaccination against the homologous AHSV serotype. Genome segment 2 (Seg-2) encodes outer capsid protein VP2, the most variable of the AHSV proteins. VP2 is also a primary target for AHSV specific neutralising antibodies, and consequently determines the identity of the nine AHSV serotypes. In contrast VP1 (the viral polymerase) and VP3 (the sub-core shell protein), encoded by Seg-1 and Seg-3 respectively, are highly conserved, representing virus species/orbivirus-serogroup-specific antigens. We report development and evaluation of real-time RT-PCR assays targeting AHSV Seg-1 or Seg-3, that can detect any AHSV type (virus species/serogroup-specific assays), as well as type-specific assays targeting Seg-2 of the nine AHSV serotypes. These assays were evaluated using isolates of different AHSV serotypes and other closely related orbiviruses, from the 'Orbivirus Reference Collection' (ORC) at The Pirbright Institute. The assays were shown to be AHSV virus-species-specific, or type-specific (as designed) and can be used for rapid, sensitive and reliable detection and identification (typing) of AHSV RNA in infected blood, tissue samples, homogenised Culicoides, or tissue culture supernatant. None of the assays amplified cDNAs from closely related heterologous orbiviruses, or from uninfected host animals or cell cultures.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983086PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0093758PLOS

Publication Analysis

Top Keywords

ahsv serotypes
12
ahsv
10
rt-pcr assays
8
african horse
8
horse sickness
8
seg-1 seg-3
8
assays targeting
8
assays
7
real time
4
time rt-pcr
4

Similar Publications

African horse sickness (AHS) is an acute, fatal, contagious disease of animals of the family Equidae and is caused by infection with the African horse sickness virus (AHSV). Based on the outer capsid protein VP2, AHSV is classified into nine serotypes (AHSV-1 to -9) with little or no serological cross-reactivity between them. In 2020, AHS outbreaks caused by AHSV-1 were reported in Thailand and Malaysia, marking the first occurrences of AHS in Southeast Asia.

View Article and Find Full Text PDF

Identification of three novel linear B-cell epitopes on VP7 of African horse sickness virus using monoclonal antibodies.

Vet Microbiol

November 2024

State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730000, China; Gansu Province Research Center for Basic Disciplines of Pathogen Biology, Lanzhou 730046, China. Electronic address:

Article Synopsis
  • * The research involved creating a recombinant version of the VP7 protein in E. coli and identifying four monoclonal antibodies that recognize specific B-cell epitopes on this protein through various immunological methods.
  • * Findings revealed conserved epitopes among different AHSV serotypes, which could aid in developing better diagnostic tools and potential vaccine strategies against AHS.
View Article and Find Full Text PDF

African horse sickness is a severe and often fatal disease affecting all species of equids. The aetiological agent, African horse sickness virus (AHSV), can be differentiated into nine serotypes. The identification of AHSV serotypes is vital for disease management, as this can influence vaccine selection and help trace disease incursion routes.

View Article and Find Full Text PDF
Article Synopsis
  • A revolutionary multivalent vaccine for African horse sickness virus (AHSV) has been developed, designed to protect against all nine serotypes using plant-produced virus-like particles (VLPs) and viral protein 2 (VP2).
  • In trials with interferon α/β receptor knock-out mice, the nonavalent vaccine outperformed the current commercial vaccine, demonstrating high neutralizing antibody levels and a strong immune response.
  • This research marks the first significant evidence of a nonavalent VP2-based vaccine's effectiveness, showcasing its potential safety and efficacy for future use in combating AHSV outbreaks.
View Article and Find Full Text PDF
Article Synopsis
  • The African horse sickness virus (AHSV) has nine serotypes and its genome consists of ten dsRNA segments, with Segment 2 (Seg-2) important for identifying the virus serotype and its neutralizing antibodies.
  • Rapid identification of AHSV serotypes is crucial for controlling outbreaks, as specific vaccination programs are needed, especially in regions where multiple serotypes can co-occur.
  • This study develops and validates three triplex real-time RT-PCR methods to quickly detect AHSV serotypes, using samples from various outbreaks in Kenya, Thailand, Nigeria, and Spain for testing.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!